The invention relates to the field of measurements of human condition parameters for diagnostic purposes, in particular to measurement of parameters characterizing human sleep.
As is known, human sleep consists of alternating phases of the so-called non-REM and REM sleep. The above phases follow each other in cycles (typically from 4 to 6 cycles) during healthy human sleep. The experience has shown that the REM phase is the most favorable to awakening. However, a great many people wake up either to the signal of alarm clock set for a specific time, or are affected by other, random factors, which means their awakening not always occurs at an optimal sleep phase. Accordingly, to provide more comfortable living conditions for people, the development of simple, small and easy-to-use technical means designed to determine sleep phase optimal for awakening and providing control over wake-up devices generating a waking sound or other signal is important.
Various methods for determining human sleep phases, including those favorable to awakening, are known.
Medical studies have found that specific sleep phases can be identified with a sufficient confidence by registering various bioelectric signals, such as EEG characterizing the bioelectric activity of the brain, electromyogram reflecting muscle activity, or EOG characterizing changes in biopotential during eye movement. However, these methods are applicable only in healthcare institutions providing the assistance of specially trained personnel and cannot be used in everyday life. Furthermore, numerous internal and external factors affect human sleep, so one and the same person's sleep can proceed in different ways. Therefore, it becomes necessary that the phase favorable to awakening be determined for a given person on the basis of his/her current psychophysiological state and sleeping conditions.
Various methods and devices are known that are designed to awaken a person during a phase of sleep favorable thereto and based on current measurements of physiological parameters of the sleeping person.
Thus, patent RU 2061406 describes a method for waking up a person during a predetermined sleep phase. For this purpose, EEG is recorded during sleep by means of sensors to identify the current REM phase and the wake-up signal generated in a predetermined interval of time is synchronized with said EEG. EEG at REM sleep, according to the authors, is distinguished by desynchronization with the emergence of beta waves in the range of 18 Hz to 32 Hz and by low-amplitude mixed activity with theta waves present.
US Patent Application 20110230790 describes a method and device for waking up a person during a required sleep phase before a predetermined ultimate wake-up time, and for identifying the best time to go bed. REM phase is identified by the motor activity registered with accelerometer attached to human leg or arm.
US Patent Application 20050190065 describes a method for waking up a person in the sleep phase the most favorable thereto. According to the authors, REM phase is characterized by cardiac blood flow increase, poor thermoregulation of body (its temperature may rise or fall depending on the ambient temperature); vasoconstriction and reduction of vascular blood flow which can be measured by peripheral arterial blood pressure monitor; unstable and increased heart rate, blood pressure and respiratory rate.
The closest to the claimed invention is the method for waking up a person at optimal time within a preset period and during a favorable sleep phase, as described in patent DE 4,209,336. REM phase is identified by measuring heart rate, respiratory rate, bodily or head temperature, and detecting eye and body movements. Devices implementing said method can be made in the form of an armband, ear clip, chest belt, etc.
The analysis of known prior art shows that such devices are not capable of identifying the onset and termination of REM sleep with sufficient reliability or said devices create a practical inconvenience to a sleeping person due to a significant number of sensors attached to the person.
The task to be solved by the present invention is to provide a simple and reliable method for identifying a sleep phase favorable to awakening, i.e., REM sleep, and capable of being embodied a device easily attached onto a person and not disturbing person's sleep.
The method in accordance with the present invention enables the identification of human sleep phases favorable to awakening by registering a pulse wave signal and movement of human limbs using, respectively, a pulse wave sensor and at least one motion sensor attached onto a person during sleep, with said pulse wave signal serving as a basis for calculating the values RR intervals and respiratory rate; wherein the onset and termination of a sleep phase favorable to awakening are identified by function increment F(Δti) whose values are determined over given time intervals Δti, where i is the serial number of the time interval; said function increments being expressed as:
F(Δti)=−K1P1−K2P2−K3P3+K4P4+K5P5K6P6, (1)
where:
P1 is the mean value of RR intervals over time interval Δti;
P2 is the minimum value of RR intervals over time interval Δti;
P3 is the maximum value of RR intervals over time interval Δti;
P4 is standard deviation of RR intervals over the preceding time interval of 3-20 min;
P5 is the mean value of respiratory rate over time interval Δti;
P6 is the average number of detected limb movements over the preceding period of 0.5-10 minutes;
K1-K6 are weight coefficients characterizing the contribution of corresponding parameter P1-P6 to function value F(Δti).
The certainty and reliability of identification of sleep phase favorable to awakening is defined by the fact experimentally established by the inventors that selected parameters P1-P6 are informative and allow, when combined, to identify the onset and termination of REM phase. On the other hand, all these parameters are determined solely by registering pulse wave signal and movements of human limbs, which requires such sensors that would not disturb human sleep when attached onto human body. Also important is the fact that the selected parameters are members of equation (1) with certain weight coefficients K1-K6 which can also be determined experimentally, thus making it possible to obtain function values F(Δti) which provide a reliable identification of the onset and termination of phase favorable to human awakening.
The limits of the time interval over which the values of parameter P4 (standard deviation of RR intervals) are measured have been established experimentally, so:
if the time interval is less than 3 minutes, the probability of the so-called Type I error (“false alarm”) grows unacceptably;
if the time interval is more than 20 minutes, the probability of the so-called Type II error (“missing the target”) grows unacceptably.
The time interval during which the value of parameter P4 is measured should be selected preferably in the range from 4 minutes to 6 minutes.
The limits of the time interval during which the value of parameter P6 (mean value of respiratory rate) is measured have also been established experimentally, so:
if the time interval is less than 0.5 minutes, the probability of Type I error grows unacceptably;
if the time interval is more than 10 minutes, the probability of Type II error grows unacceptably.
The time interval during which the value of parameter P6 is determined should be selected preferably in the range from 4 minutes to 6 minutes.
In particular, the following values of weight coefficients for healthy people have been experimentally determined:
for parameter P1 measured in ms, the value of weight coefficient K1 may be selected in the range from 0.6 ms−1 to 3 ms−1, preferably from 0.9 ms−1 to 1.05 ms−1;
for parameter P2, measured in ms, the value of weight coefficient K2 may be selected in the range from 0.1 ms−1 to 0.7 ms−1, preferably from 0.1 ms−1 to 0.2 ms−1;
for parameter P3, measured in ms, the value of weight coefficient K3 may be selected in the range from 0.01 ms−1 to 0.3 ms−1, preferably from 0.02 ms−1 to 0.05 ms−1;
for parameter P4, measured in ms, the value of weight coefficient K4 may be selected in the range from 0.5 ms−1 to 3 ms−1, preferably from 1.3 ms−1 to 1.5 ms−1;
for parameter P5, measured in min−1, the value of weight coefficient K5 may be selected in the range from 1 min to 10 min, preferably from 1.5 min to 2.3 min;
for parameter P6 the value of weight coefficient K6 can be selected in the range from 5 to 50, preferably from 18 to 24.
In particular implementations of the method, pulse wave may be registered using piezoelectric sensor, strain gage, or optical sensor fixed on the wrist or forearm, while the motion detector can be represented by an accelerometer fixed on the arm or leg.
Time intervals Δti may be selected in the range from 1 minute to 6 minutes.
In particular, the onset of sleep phase favorable to awakening is identified if the increment of function F(Δti) over time period Δti exceeds a first preset threshold value.
In particular, the end of sleep phase favorable to awakening is identified if the increment of function F(Δti) over time period Δti becomes less than a second preset threshold value.
The invention is illustrated by the following graphic materials:
A method for determining the sleep phase favorable to awakening can be implemented using two sensors: a pulse wave sensor and a sensor capable of responding to arm or leg movement, i.e., a motion sensor such as an accelerometer. The sensors can be mounted on a human body separately from each other. For example, the motion sensor can be attached to an arm or a leg, while the pulse wave sensor onto the wrist or forearm. Pulse wave sensors may be represented by piezoelectric sensors, strain gages, and optical sensors. The use of an optical sensor or photoplethysmographic sensor sensitive to vascular blood filling of bodily areas is preferable. It is more convenient for the user if both pulse wave sensor and motion sensor are mounted in a single device, such as shown in
As shown in
The values of RR intervals and respiratory rate are determined in human sleep based on registered pulse wave signal. Since a pulse wave signal is a periodic signal that varies in synchronism with heartbeat, the time intervals between any characteristic points on pulsogram (e.g., peak value of the signal or its derivative) correspond exactly to RR intervals. Instrumental methods for determining heart rate or RR intervals from a pulse wave signal are well known to those skilled in the art. It is also known that, alongside with the above-mentioned periodic variations corresponding to blood filling dynamics at each cardiac cycle, pulse wave signal includes a low frequency component corresponding to respiratory cycle. Instrumental methods of determining the respiratory rate based on low-pass filtering of respiratory component out of pulse wave signal are well known to those skilled in the art.
Thereafter, using the obtained data, i.e., values of RR intervals and respiration rate, the following parameters are periodically measured at in preset time intervals Δti:
P1—the mean value of RR intervals;
P2—the minimum value of RR intervals;
P3—the maximum value of RR intervals;
P5—the mean respiratory rate.
The time interval Δti over which said parameters are measured is selected in the range from 1 minute to 6 minutes. Here, i is the serial number of i-th time interval.
Furthermore, parameter P4 is determined as the standard deviation of RR intervals over the preceding time interval of 3 minutes to 20 minutes, preferably from 4 minutes to 6 minutes.
The mean number of limb movements P6 over the preceding time interval from 0.5 minutes to 10 minutes, preferably from 4 minutes to 6 minutes, is another parameter needed for final identification of REM sleep phase. Since the occurrence of motor activity is informative by itself for identification of REM sleep, all limb movements detected by accelerometer over a 10 seconds period are taken for one movement.
Thereafter, function value F(Δti) is determined by formula:
F(Δti)=−K1P1−K2P2−K3P3+K4P4+K5P5K6P6,
where: K1-K6 are weight coefficients characterizing the contribution of corresponding parameter P1-P6 to the value of F(Δti).
Table 1 below shows the value ranges of weight coefficients K1-K6, as well optimal value thereof.
Informative parameters P1-P6 were established, and their weight coefficients K1-K6 for healthy people were obtained experimentally based on polysomnographic clinical studies. Statistically valid methods accepted in medical practice and described, for example, in the article “Polysonmography” (http://www.zonasna.ru/serv002.html) were used for checking the accuracy of REM sleep identification. Weight coefficients K1-K6 were selected so that the function values F(Δti) in REM and non-REM phases display a maximum difference from each other.
The increment ΔF(Δti) of function F(Δti)) over time Δti is used to identify the onset and termination of REM sleep. If the difference between the current function value F(Δti) and its previous value F(Δti-1) exceeds the first preset threshold value, the onset of REM sleep is identified. If said difference is less than the second preset threshold value, the termination of REM sleep is identified.
The measuring resolution of accelerometer and pulse wave sensor signals amounted 0.1 in the testing process. All limb movements detected over 10-second time interval were considered to be a single movement and were averaged over the period of 5 min Function values F(Δti) were calculated every minute, in other words, value Δti was taken to be 1 minute for each i-th time interval. The first threshold value L1 was selected in the range from 20 to 30, while the second threshold value L2 was selected in the range from −30 to −20.
The example illustrated in
202
1206
1015
1290
89
18
0
0
−1226
96.1
210
1367
1290
1500
97
14
1
0.2
−1424
−199.6
The number of REM phases may vary during sleep. For example,
The graph also shows that different REM phases feature different absolute values of function F(Δti) throughout sleep duration and that REM sleep onset and termination can be reliably identified only by the increment of said function.
A series of tests showed that the method according to the present invention enabled the identification of 73 out of 76 REM sleep phases in 20 test subjects, which testifies to its high reliability of identification of human sleep phase favorable to awakening. The parameters of function F(Δti) selected therein were also defined by the necessity to use a minimum number of sensors fixed on the wrist to provide comfortable sleeping conditions.
This application is a Continuation application of International Application PCT/RU2014/000237, filed on Apr. 2, 2014, which in turn claims priority to Russian Patent Application No. RU 2013116790, filed Apr. 5, 2013, both of which are incorporated herein by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
4306567 | Krasner | Dec 1981 | A |
5280791 | Lavie | Jan 1994 | A |
20040034289 | Teller | Feb 2004 | A1 |
20050190065 | Ronnholm | Sep 2005 | A1 |
20060111635 | Todros et al. | May 2006 | A1 |
20060241510 | Halperin | Oct 2006 | A1 |
20080269625 | Halperin et al. | Oct 2008 | A1 |
20090203972 | Heneghan | Aug 2009 | A1 |
20110230790 | Kozlov | Sep 2011 | A1 |
20110264164 | Christopherson | Oct 2011 | A1 |
20120083705 | Yuen | Apr 2012 | A1 |
20130261404 | Sato | Oct 2013 | A1 |
20140327515 | Luna | Nov 2014 | A1 |
20150112606 | He | Apr 2015 | A1 |
Number | Date | Country |
---|---|---|
4209336 | Sep 1993 | DE |
2003260040 | Sep 2003 | JP |
20120045661 | May 2012 | KR |
2061406 | Jun 1996 | RU |
2007143535 | Dec 2007 | WO |
Entry |
---|
Miele “Polysonmography,” http://www.zonasna.ru/serv002.html, Feb. 21, 2010. |
International Search Report from International Application No. PCT/RU2014/000237, filed Apr. 2, 2014, dated Aug. 28, 2014. |
Tsiboulsky et al, On Functional Role of Paradoxical Phase of Sleep, The Central Mechanisms of Motivation and Sensory Processes: Coll. Art, 1988, pp. 113-120, Baku. |
Gecht et al., Sleep-Wakefulness Cycle: Nightdreams and Health, Journal of New Medical Technologies, 1994, v. 1, No. 2, pp. 45-50. |
Number | Date | Country | |
---|---|---|---|
20160007931 A1 | Jan 2016 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/RU2014/000237 | Apr 2014 | US |
Child | 14865879 | US |